Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer

@article{Xu2015PrognosticVO,
  title={Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer},
  author={Youtao Xu and Lei Xu and Mantang Qiu and Jie Jin Wang and Qing Zhou and Lin Xu and Jian You Wang and Rong Yin},
  journal={Scientific Reports},
  year={2015},
  volume={5}
}
  • Youtao Xu, Lei Xu, +5 authors Rong Yin
  • Published 2015
  • Medicine
  • Scientific Reports
  • The role of serum CYFRA 21-1 level in patients with non-small cell lung cancer (NSCLC) remains to be defined. To re-evaluate the impact of serum CYFRA 21-1 in NSCLC survival, we performed this meta-analysis. Databases were searched to identify relevant studies reported after the publication of a meta-analysis in 2004. Totally, 31 studies with 6394 patients were included in this meta-analysis. The pooled Hazard ratios (HRs) indicated that high CYFRA 21-1 level was associated with poor prognosis… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 16 CITATIONS

    Establishment of reference interval for the tumour marker serum CYFRA 21-1 in healthy Chinese Han ethnic adults

    Hypoxia associated biomarkers in lung cancer - an update.

    • W-G Cui, F-l Wu, L Ma
    • Medicine
    • European review for medical and pharmacological sciences
    • 2017